Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Verdecchia, C. Cavallini, A. Spanevello, F. Angeli (2020)
The pivotal link between ACE2 deficiency and SARS-CoV-2 infectionEuropean Journal of Internal Medicine, 76
D. Colatutto, A. Sonaglia, A. Zabotti, L. Cereser, R. Girometti, L. Quartuccio (2021)
Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the LiteratureViruses, 13
(Yokogawa N, Minematsu N, Katano H, Suzuki T. Case of acute arthritis following SARS-CoV-2 infection. Ann Rheum Dis 2020;;annrheumdis-2020-218281.)
Yokogawa N, Minematsu N, Katano H, Suzuki T. Case of acute arthritis following SARS-CoV-2 infection. Ann Rheum Dis 2020;;annrheumdis-2020-218281.Yokogawa N, Minematsu N, Katano H, Suzuki T. Case of acute arthritis following SARS-CoV-2 infection. Ann Rheum Dis 2020;;annrheumdis-2020-218281., Yokogawa N, Minematsu N, Katano H, Suzuki T. Case of acute arthritis following SARS-CoV-2 infection. Ann Rheum Dis 2020;;annrheumdis-2020-218281.
K. Lokugamage, Adam Hage, M. Vries, Ana Valero-Jimenez, Craig Schindewolf, Meike Dittmann, Ricardo Rajsbaum, Vineet Menachery (2020)
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoVJournal of Virology, 94
Rashmi Roongta, A. Chattopadhyay, Alakendu Ghosh (2021)
Correspondence on ‘Onset of rheumatoid arthritis after COVID-19: coincidence or connected?’Annals of the Rheumatic Diseases, 82
A. Abdullahi, S. Candan, M. Abba, Auwal Bello, Mansour Alshehri, Egwuonwu Victor, N. Umar, B. Kundakci (2020)
Neurological and Musculoskeletal Features of COVID-19: A Systematic Review and Meta-AnalysisFrontiers in Neurology, 11
W. Guan, Z. Ni, Yu Hu, W. Liang, C. Ou, Jianxing He, Lei Liu, H. Shan, C. Lei, D. Hui, Bin Du, Lanjuan Li, G. Zeng, K. Yuen, Ru-chong Chen, C. Tang, Taojiao Wang, Ping-yan Chen, J. Xiang, Shi‐yue Li, Jin-lin Wang, Ziyao Liang, Yi-xiang Peng, Li Wei, Yong Liu, Ya-hua Hu, P. Peng, Jian-ming Wang, Ji-yang Liu, Zhong Chen, Gang Li, Zhi-jian Zheng, Shao-qin Qiu, Jie Luo, C. Ye, Shao-yong Zhu, N. Zhong (2020)
Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine
C. Fernández‐de‐las‐Peñas, D. Palacios-Ceña, Víctor Gómez-Mayordomo, M. Cuadrado, L. Florêncio (2021)
Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative ClassificationInternational Journal of Environmental Research and Public Health, 18
(Roongta R, Chattopadhyay A, Ghosh A. Correspondence on “onset of rheumatoid arthritis after COVID-19: coincidence or connected?”. Ann Rheum Dis 2021;;annrheumdis-2021-220479.)
Roongta R, Chattopadhyay A, Ghosh A. Correspondence on “onset of rheumatoid arthritis after COVID-19: coincidence or connected?”. Ann Rheum Dis 2021;;annrheumdis-2021-220479.Roongta R, Chattopadhyay A, Ghosh A. Correspondence on “onset of rheumatoid arthritis after COVID-19: coincidence or connected?”. Ann Rheum Dis 2021;;annrheumdis-2021-220479., Roongta R, Chattopadhyay A, Ghosh A. Correspondence on “onset of rheumatoid arthritis after COVID-19: coincidence or connected?”. Ann Rheum Dis 2021;;annrheumdis-2021-220479.
(Beydon M, Chevalier K, Al Tabaa O, et al. Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis 2020;; annrheumdis-2020-217573.)
Beydon M, Chevalier K, Al Tabaa O, et al. Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis 2020;; annrheumdis-2020-217573.Beydon M, Chevalier K, Al Tabaa O, et al. Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis 2020;; annrheumdis-2020-217573., Beydon M, Chevalier K, Al Tabaa O, et al. Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis 2020;; annrheumdis-2020-217573.
(2019)
World Health Organization. Coronavirus disease (COVID-19) outbreak
M. Beydon, K. Chevalier, O. Tabaa, S. Hamroun, Anne-Sophie Delettre, M. Thomas, J. Herrou, E. Rivière, X. Mariette (2020)
Myositis as a manifestation of SARS-CoV-2Annals of the Rheumatic Diseases, 80
Isabel Fragata, A. Mourão (2020)
Coronavirus Disease 19 (COVID-19) complicated with post-viral arthritis.Acta reumatologica portuguesa, 45 4
J. Peiris, Kwok-yung Yuen, A. Osterhaus, Klaus Stöhr (2003)
The Severe Acute Respiratory SyndromeNew and Evolving Infections of the 21st Century
Shao Li, Rui-qin Wang, Yulong Zhang, Xuegong Zhang, A. Layon, Yanda Li, Mingzhe Chen (2006)
Symptom combinations associated with outcome and therapeutic effects in a cohort of cases with SARS.The American journal of Chinese medicine, 34 6
(2004)
Severe acute respiratory syndromeClin Infect Dis, 38
Nehemya Friedman, H. Alter, M. Hindiyeh, E. Mendelson, Y. Avni, M. Mandelboim (2018)
Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1Viruses, 10
Sairam Raghavan, S. Gonakoti, I. Asemota, Benjamin Mba (2020)
A Case of Systemic Lupus Erythematosus Flare Triggered by Severe Coronavirus Disease 2019Journal of Clinical Rheumatology, 26
(WHO Coronavirus disease (COVID-19) Dashboard [online]. Available at: https://covid19.who.int/region/emro/country/eg. (accessed 27.09.2021).)
WHO Coronavirus disease (COVID-19) Dashboard [online]. Available at: https://covid19.who.int/region/emro/country/eg. (accessed 27.09.2021).WHO Coronavirus disease (COVID-19) Dashboard [online]. Available at: https://covid19.who.int/region/emro/country/eg. (accessed 27.09.2021)., WHO Coronavirus disease (COVID-19) Dashboard [online]. Available at: https://covid19.who.int/region/emro/country/eg. (accessed 27.09.2021).
S. Bhaskar, A. Sinha, Maciej Banach, S. Mittoo, Robert Weissert, J. Kass, Santhosh Rajagopal, Anupama Pai, S. Kutty (2020)
Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position PaperFrontiers in Immunology, 11
(1926)
The technique of the red cell sedimentation reaction
Bruno Andrade, S. Siqueira, Wagner Soares, Fernanda Rangel, N. Santos, Andria Freitas, Priscila Silveira, S. Tiwari, Khalid Alzahrani, A. Góes-Neto, V. Azevedo, P. Ghosh, D. Barh (2021)
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular MechanismsViruses, 13
Sakir Ahmed, O. Zimba, A. Gasparyan (2021)
COVID-19 and the clinical course of rheumatic manifestationsClinical Rheumatology, 40
E. Saricaoğlu, I. Hasanoğlu, R. Guner (2020)
The first reactive arthritis case associated with COVID‐19Journal of Medical Virology, 93
Hengbo Zhu, Li Wei, Ping Niu (2020)
The novel coronavirus outbreak in Wuhan, ChinaGlobal Health Research and Policy, 5
L. Novelli, F. Motta, M. Santis, A. Ansari, M. Gershwin, C. Selmi (2020)
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literatureJournal of Autoimmunity, 117
A. Baig (2020)
Chronic COVID syndrome: Need for an appropriate medical terminology for long‐COVID and COVID long‐haulersJournal of Medical Virology, 93
Yujun Tang, Jiajia Liu, Dingyi Zhang, Zhenghao Xu, Jin-jun Ji, Chengping Wen (2020)
Cytokine Storm in COVID-19: The Current Evidence and Treatment StrategiesFrontiers in Immunology, 11
Mengyuan Li, Lin Li, Yue Zhang, Xiaosheng Wang (2020)
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissuesInfectious Diseases of Poverty, 9
(World Health Organization. Coronavirus disease (COVID-19) outbreak. 2019. Available frome: https://www.who.int/emereencies/diseases/novel—coronavirus-2019/situation-reports. (accessed 11/04/2020).)
World Health Organization. Coronavirus disease (COVID-19) outbreak. 2019. Available frome: https://www.who.int/emereencies/diseases/novel—coronavirus-2019/situation-reports. (accessed 11/04/2020).World Health Organization. Coronavirus disease (COVID-19) outbreak. 2019. Available frome: https://www.who.int/emereencies/diseases/novel—coronavirus-2019/situation-reports. (accessed 11/04/2020)., World Health Organization. Coronavirus disease (COVID-19) outbreak. 2019. Available frome: https://www.who.int/emereencies/diseases/novel—coronavirus-2019/situation-reports. (accessed 11/04/2020).
M. Marshall (2020)
The lasting misery of coronavirus long-haulersNature, 585
Keisuke Ono, M. Kishimoto, Teppei Shimasaki, H. Uchida, Daisuke Kurai, G. Deshpande, Y. Komagata, S. Kaname (2020)
Reactive arthritis after COVID-19 infectionRMD Open, 6
S. Amin, J. Niu, A. Guermazi, M. Grigoryan, D. Hunter, M. Clancy, M. Lavalley, H. Genant, D. Felson (2006)
Cigarette smoking and the risk for cartilage loss and knee pain in men with knee osteoarthritisAnnals of the Rheumatic Diseases, 66
N. Yokogawa, N. Minematsu, H. Katano, Tadaki Suzuki (2020)
Case of acute arthritis following SARS-CoV-2 infectionAnnals of the Rheumatic Diseases, 80
M. Gasparotto, V. Framba, C. Piovella, A. Doria, L. Iaccarino (2021)
Post-COVID-19 arthritis: a case report and literature reviewClinical Rheumatology, 40
R. Rubin (2020)
As Their Numbers Grow, COVID-19 "Long Haulers" Stump Experts.JAMA
Yu Liu, A. Sawalha, Q. Lu (2020)
COVID-19 and autoimmune diseasesCurrent Opinion in Rheumatology, 33
B. Koçyiğit, A. Akyol (2021)
Reactive arthritis after COVID-19: a case-based reviewRheumatology International, 41
M. Mukarram, Muhammad Ghauri, S. Sethar, Nasir Afsar, A. Riaz, Khizra Ishaq (2021)
COVID-19: An Emerging Culprit of Inflammatory ArthritisCase Reports in Rheumatology, 2021
D. Aletaha, J. Smolen (2018)
Diagnosis and Management of Rheumatoid Arthritis: A ReviewJAMA, 320
M. Marks, J. Marks (2016)
Viral arthritis.Clinical medicine, 16 2
BackgroundVarious musculoskeletal and autoimmune manifestations have been described in patients with coronavirus disease 2019 (COVID-19).ObjectivesThis study aims to investigate the prevalence and etiology of arthritis in post-COVID Egyptian patients.MethodsWe included 100 post-COVID Egyptian patients who recovered 6 months ago and assessed several inflammatory and autoimmune markers.ResultsThe prevalence of post-COVID arthritis was 37%. Ankle, knee, and wrist were the most commonly affected joints. Old age (P = 0.010), smoking (P = 0.001), and arthralgia (P = 0.049) were all linked with post-COVID arthritis. Levels of pretreatment (baseline) interleukin (IL)-6 (46.41 ± 3.67 vs. 24.03 ± 2.46; P = 0.001), as well as 6-month post-COVID C-reactive protein (CRP; 98.49 ± 67.55 vs. 54.32 ± 65.73; P = 0.002), and erythrocyte sedimentation rate (ESR; 109.08 ± 174.91 vs. 58.35 ± 37.87; P = 0.029) were significantly higher in patients with arthritis compared to those without. On the other hand, complement C3 (P = 0.558) and C4 (P = 0.192), anti-nuclear antibodies (P = 0.709), and anti-cyclic citrullinated peptides (anti-CCP; P = 0.855) did not show significant differences. Only pretreatment IL-6 level was the significant single predictor of post-COVID arthritis with an odds ratio (95% confidence interval) of 3.988 (1.460–10.892) and a P-value of 0.007.ConclusionThe strong association observed with inflammatory markers (ESR and CRP) and the insignificant association with serologic markers of autoimmunity (ANA and anti-CCP) in our study support the notion that the underlying mechanism of post-COVID-19 arthritis is primarily due to the hyperinflammatory process associated with COVID-19 infection, and not the result of an autoimmune reaction. IL-6 levels before therapy can predict post-COVID arthritis allowing for early management.
European Cytokine Network – Springer Journals
Published: Dec 1, 2021
Keywords: Autoimmunity; Hyperinflammation; Musculoskeletal; Arthritis; Post-COVID; Rheumatology
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.